PMID: 2506598Jan 1, 1989Paper

Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls

Psychopharmacology
T SunderlandE A Mueller

Abstract

Ten patients with Alzheimer's disease and ten age-matched normal controls were studied in a double-blind, placebo-controlled acute trial of 1 mg PO lorazepam to test the effects of low-dose benzodiazepine on memory and behavior in a mostly older population. Cognitive effects differed somewhat between Alzheimer patients and normal controls, with Alzheimer patients revealing predominantly "attentional" impairments and age-matched controls showing possible "disinhibition." Specifically, Alzheimer patients made more omission errors on a continuous performance task, whereas controls made more commission and intrusion errors with lorazepam versus placebo. This low dose of lorazepam (1 mg), which was associated with mild but statistically significant sedation in both groups, also produced no significant decrease in recent memory or in access to semantic memory. These cognitive findings contrast markedly to the reported effects of scopolamine on recent memory; therefore, supporting the idea that cholinergic interruption has a more specific effect on human memory and on learning than that of low-dose benzodiazepines. Further studies with a wider dose range of benzodiazepines are necessary to evaluate the possibility of differential sens...Continue Reading

References

Mar 1, 1977·Clinical Pharmacology and Therapeutics·D J GreenblattR I Shader
Feb 1, 1977·British Journal of Clinical Pharmacology·K A George, J W Dundee
Apr 15, 1978·Experientia·J BrownJ B Bowes
May 1, 1978·Journal of Clinical Pharmacology·J T ConnerF Dorey
May 1, 1979·Archives of Neurology·E O ClarkH Turndorf
Sep 1, 1975·Archives of Neurology·V C HachinskiL Symon
Jan 1, 1988·Trends in Neurosciences·M SarterD N Stephens
Jun 1, 1986·Archives of General Psychiatry·D W HommerS M Paul
Feb 1, 1987·Journal of Neurochemistry·J T GreenamyreA B Young
Jan 1, 1987·European Journal of Clinical Pharmacology·A PatatM Hucher
Jan 1, 1987·Psychopharmacology·P P Roy-ByrneH Weingartner
Jan 1, 1988·Psychopharmacology·G C PrestonS M Stahl
Jan 1, 1986·Progress in Neuro-psychopharmacology & Biological Psychiatry·T SunderlandR M Cohen
Jun 1, 1987·Pharmacology, Biochemistry, and Behavior·A M NikaidoD Dubow
May 1, 1986·Clinical Pharmacology and Therapeutics·R I ShaderD J Greenblatt
Jan 1, 1987·The American Journal of Psychiatry·O M WolkowitzD W Hommer
Nov 1, 1971·Science·J A Deutsch
Feb 1, 1974·Archives of Neurology·D A Drachman, J Leavitt
Jan 1, 1972·British Journal of Pharmacology·J W Dundee, S K Pandit
Aug 1, 1970·British Journal of Anaesthesia·P R ClarkeJ A Thornton
Feb 1, 1984·Pharmacology, Biochemistry, and Behavior·R I Block, R Berchou
Feb 1, 1983·Psychiatry Research·R M CohenD L Murphy
Jan 1, 1984·Psychopharmacology·R G Lister, S E File
Dec 1, 1984·Behavioural Brain Research·J T RichardsonD Cunningham-Owens
Oct 1, 1983·Clinical Pharmacology and Therapeutics·J K WalshS Parwatikar
Sep 1, 1982·The Medical Clinics of North America·B R Meyer
Jun 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·C P HughesR L Martin
Sep 1, 1982·The American Journal of Psychiatry·B ReisbergT Crook
Oct 1, 1956·Journal of Consulting Psychology·L H BECKI SARASON

❮ Previous
Next ❯

Citations

Sep 1, 1992·Brain Research. Brain Research Reviews·S E MolchanT Sunderland
Feb 1, 1997·Progress in Neuro-psychopharmacology & Biological Psychiatry·N Ludvig
Jun 17, 2004·Journal of Basic and Clinical Physiology and Pharmacology·Jan J BraszkoPaul R Gard
Jul 9, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Craig D C BaileyEvelyn K Lambe
Oct 15, 2013·Cellular and Molecular Life Sciences : CMLS·Eliane ProulxEvelyn K Lambe
Apr 26, 2013·Journal of Gerontological Nursing·Nicole J Brandt, Jessica Pythtila
Feb 11, 2011·British Journal of Clinical Pharmacology·Marieke Liem-MoolenaarJoop M A van Gerven
Apr 12, 2016·Frontiers in Pharmacology·Lieven D DeclercqGuy Bormans
May 21, 2015·The International Journal of Neuropsychopharmacology·Michaela DefrancescoImrich Blasko
Oct 28, 1998·Journal of Clinical Psychopharmacology·M BourinB Guitton
Nov 21, 2007·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Nathan Herrmann, Krista L Lanctôt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.